Please assess the completion status of the following clinical trial:

Trial Title: Bifocal Right Ventricular PAcing in Right Bundle Branch blocK and Heart Failure With Reduced Ejection Fraction. The Study Tests the Superiority of Right Ventricular Bifocal Stimulation Over VVI Implantable Defibrillator in Right Bundle Branch Block and Heart Failure.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with RBBB and HFrEF (defined by left ventricular ejection fraction ≤35%) in sinus rhythm, who remain in NYHA class II-III or ambulatory NYHA class IV despite OMT.~Exclusion Criteria:~* Refusal or withdrawal of informed consent.~* Renal failure (defined by an estimated glomerular filtration rate ≤ 60 ml/min)~* Life expectancy \< 12 months~* Active neoplasm~* Permanent atrial fibrillation~* 40 days following acute coronary syndrome~* Atrio-ventricular block (from second degree AV block)~* Valvular heart disease with surgery indications

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bifocal stimulation (Type: ACTIVE_COMPARATOR): Active comparator is represented by programming bifocal stimulation (bifocal DDD mode). Every patients will undergo crossover randomization (from bifocal DDD mode to VVI and vice versa).
- VVI 40 (Type: PLACEBO_COMPARATOR): Placebo comparator is represented by programming the device in VVI mode 40/mins. Every patients will undergo crossover randomization (from VVI to bifocal DDD mode and vice versa).

Based on this trial design, predict the completion outcome and termination type (if applicable).